BR112012000760B8 - composição nutricional - Google Patents
composição nutricionalInfo
- Publication number
- BR112012000760B8 BR112012000760B8 BR112012000760A BR112012000760A BR112012000760B8 BR 112012000760 B8 BR112012000760 B8 BR 112012000760B8 BR 112012000760 A BR112012000760 A BR 112012000760A BR 112012000760 A BR112012000760 A BR 112012000760A BR 112012000760 B8 BR112012000760 B8 BR 112012000760B8
- Authority
- BR
- Brazil
- Prior art keywords
- nutritional composition
- oligosaccharides
- immune system
- composition
- digible
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 235000016709 nutrition Nutrition 0.000 title abstract 2
- 210000000987 immune system Anatomy 0.000 abstract 2
- 229920001542 oligosaccharide Polymers 0.000 abstract 2
- RTVRUWIBAVHRQX-PMEZUWKYSA-N Fucosyllactose Chemical compound C([C@H]1O[C@@H]([C@H]([C@@H](O[C@@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@@H]1O)O)OC)O[C@H]1OC[C@@H](O)[C@H](O)[C@@H]1O RTVRUWIBAVHRQX-PMEZUWKYSA-N 0.000 abstract 1
- 150000002482 oligosaccharides Chemical class 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Molecular Biology (AREA)
- Pediatric Medicine (AREA)
- Communicable Diseases (AREA)
- Obesity (AREA)
- Transplantation (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Otolaryngology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09165543.1 | 2009-07-15 | ||
EP9165543.1 | 2009-07-15 | ||
EP09165543 | 2009-07-15 | ||
US25595009P | 2009-10-29 | 2009-10-29 | |
US61/255,950 | 2009-10-29 | ||
PCT/NL2010/050446 WO2011008086A1 (en) | 2009-07-15 | 2010-07-12 | Mixture of non-digestible oligosaccharides for stimulating the immune system |
Publications (3)
Publication Number | Publication Date |
---|---|
BR112012000760A2 BR112012000760A2 (pt) | 2018-03-13 |
BR112012000760B1 BR112012000760B1 (pt) | 2021-04-27 |
BR112012000760B8 true BR112012000760B8 (pt) | 2022-09-20 |
Family
ID=41055196
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012000760A BR112012000760B8 (pt) | 2009-07-15 | 2010-07-12 | composição nutricional |
Country Status (8)
Country | Link |
---|---|
US (3) | US20120178674A1 (pt) |
EP (3) | EP2453902B1 (pt) |
CN (3) | CN106890329A (pt) |
BR (1) | BR112012000760B8 (pt) |
ES (1) | ES2433429T3 (pt) |
MY (1) | MY189329A (pt) |
PL (1) | PL2453902T3 (pt) |
WO (1) | WO2011008086A1 (pt) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2530641C2 (ru) * | 2009-07-15 | 2014-10-10 | Н.В. Нютрисиа | Фукозиллактоза в качестве неусвояемого олигосахарида, идентичного грудному молоку, с новой функциональной пользой |
CN106890329A (zh) | 2009-07-15 | 2017-06-27 | N·V·努特里奇亚 | 用于刺激免疫***的不可消化低聚糖的混合物 |
EP2454948A1 (en) | 2010-11-23 | 2012-05-23 | Nestec S.A. | Oligosaccharide mixture and food product comprising this mixture, especially infant formula |
JP6129821B2 (ja) | 2011-05-13 | 2017-05-17 | グリコシン リミテッド ライアビリティー カンパニー | プレバイオティクスとしての、精製された2’−フコシルラクトース、3−フコシルラクトース、およびラクトジフコテトラオースの使用 |
NL2007268C2 (en) | 2011-08-16 | 2013-02-19 | Friesland Brands Bv | Nutritional compositions comprising human milk oligosaccharides and uses thereof. |
US9781947B2 (en) * | 2011-10-18 | 2017-10-10 | Nestec S.A. | Composition for use in the promotion of magnesium absorption and/or magnesium retention |
EP2811845B1 (en) * | 2012-02-10 | 2015-12-09 | N.V. Nutricia | Maternal supplement to enhance immune system of an infant |
WO2013117234A1 (en) * | 2012-02-10 | 2013-08-15 | N.V. Nutricia | Maternal composition for enhancing immune system |
PT3068404T (pt) | 2013-11-15 | 2021-03-22 | Nestle Sa | Composições para utilização na prevenção ou tratamento de infecções do urt em lactentes ou crianças pequenas em risco |
MX2016005408A (es) | 2013-11-15 | 2016-08-11 | Nestec Sa | Ficomposiciones para prevenir o tratar alergias en infantes a partir de o alimentados por madres no secretoras mediante el suministro de oligosacaridos fucosilados, particularmente entre los niños en riesgo o nacidos por cesarea. |
US10568896B2 (en) | 2013-11-19 | 2020-02-25 | Abbott Laboratories | Methods for preventing or mitigating acute allergic responses using human milk oligosaccharides |
WO2015136304A1 (en) * | 2014-03-13 | 2015-09-17 | Isis Innovation Limited | Polyamine compounds and uses thereof |
US10792294B2 (en) * | 2014-04-08 | 2020-10-06 | Abbott Laboratories | Methods for enhancing mucosal innate immune responses to and/or detection of pathogens using human milk oligosaccharides |
CA3228982A1 (en) | 2014-07-09 | 2016-01-14 | Dsm Nutritional Products, Llc | Oligosaccharide compositions and methods for producing thereof |
SI3354282T1 (sl) | 2015-01-26 | 2021-07-30 | Kaleido Biosciences, Inc. | Glikanski terapevtiki in z njimi povezani postopki |
US10849337B2 (en) | 2015-01-26 | 2020-12-01 | Cadena Bio, Inc. | Oligosaccharide compositions for use as animal feed and methods of producing thereof |
WO2016138911A1 (en) | 2015-03-05 | 2016-09-09 | Glycom A/S | Composition and method for treating acute respiratory tract infections |
EP3285777B1 (en) * | 2015-04-23 | 2021-06-09 | Kaleido Biosciences, Inc. | Glycan therapeutics and methods of treatment |
EP3349790A1 (en) * | 2015-09-18 | 2018-07-25 | Rijksuniversiteit Groningen | Long chain inulin for stimulating an immune response |
EP3592363A1 (en) * | 2017-03-08 | 2020-01-15 | N.V. Nutricia | Composition with non-digestible oligosaccharides for attenuating nasal epithelial inflammation |
WO2019031961A1 (en) * | 2017-08-11 | 2019-02-14 | N.V. Nutricia | OLIGOSACCHARIDE OF HUMAN MILK TO IMPROVE PHYSICAL IMMUNE CONDITION |
US11524019B2 (en) | 2017-08-21 | 2022-12-13 | Glycom A/S | Synthetic composition for reducing allergy symptoms |
CN107373674A (zh) * | 2017-08-25 | 2017-11-24 | 西宝生物科技(上海)股份有限公司 | 一种肿瘤治疗后的营养组合物及其应用 |
EP3784268A4 (en) | 2018-04-25 | 2022-04-27 | Health and Happiness (H&H) Hong Kong Limited | COMBINATIONS OF OSTEOPONTIN AND 2'-FUCOSYLLACTOSE FOR USE AS MEDICINES |
EP3883393B1 (en) | 2019-06-04 | 2022-09-07 | N.V. Nutricia | Nutritional composition comprising 2'fucosyllactose and dietary butyrate |
TW202128190A (zh) * | 2019-10-24 | 2021-08-01 | 荷蘭商弗里斯蘭康必奶荷蘭有限公司 | 用於預防氣喘的包含2’-岩藻糖基乳糖之組成物 |
CN111011864A (zh) * | 2019-12-27 | 2020-04-17 | 内蒙古蒙牛乳业(集团)股份有限公司 | 一种促进肠道健康的营养组分 |
CN112063699B (zh) * | 2020-09-16 | 2021-06-18 | 成都市疾病预防控制中心 | 一种用于研究hiv感染者免疫衰老机制的*** |
CA3210075A1 (en) | 2021-04-13 | 2022-10-20 | Petronella Johanna Looijesteijn | Nutritional composition for stimulationg bifidobacteria |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5002759A (en) | 1989-07-25 | 1991-03-26 | Colgate-Palmolive Company | Oligosaccharide inhibition of Streptococcus pyogenes adhesion |
US6204431B1 (en) | 1994-03-09 | 2001-03-20 | Abbott Laboratories | Transgenic non-human mammals expressing heterologous glycosyltransferase DNA sequences produce oligosaccharides and glycoproteins in their milk |
DE19701382A1 (de) | 1997-01-16 | 1998-07-23 | Nutricia Nv | Kohlenhydratmischung |
US6045854A (en) * | 1997-03-31 | 2000-04-04 | Abbott Laboraties | Nutritional formulations containing oligosaccharides |
US20020019991A1 (en) | 1998-04-30 | 2002-02-14 | Abbott Laboratories | Compositions containing an alpha 1,2-fucose linkage and uses thereof |
DE19836339B4 (de) | 1998-08-11 | 2011-12-22 | N.V. Nutricia | Kohlenhydratmischung |
AU2000237154A1 (en) | 2000-02-28 | 2001-09-12 | Zila, Inc. | Method for detecting and killing epithelial cancer cells |
ES2232591T3 (es) | 2000-03-01 | 2005-06-01 | Societe Des Produits Nestle S.A. | Formulacion de hidratos de carbono (adyuvante prebiotico) para la mejora de la respuesta inmune. |
RU2388478C2 (ru) * | 2003-10-24 | 2010-05-10 | Н.В. Нютрисиа | Иммуномодулирующие олигосахариды |
CN1870910B (zh) | 2003-10-24 | 2010-05-26 | 努特里奇亚有限公司 | 婴儿合生素组合物 |
WO2005055944A2 (en) | 2003-12-05 | 2005-06-23 | Cincinnati Children's Hospital Medical Center | Oligosaccharide compositions and use thereof in the treatment of infection |
EP1597978A1 (en) | 2004-05-17 | 2005-11-23 | Nutricia N.V. | Synergism of GOS and polyfructose |
ATE361101T1 (de) | 2004-08-24 | 2007-05-15 | Nutricia Nv | Nahrungszusammensetzung die unverdauliche oligosaccharide enthält |
AU2006215603A1 (en) | 2005-02-21 | 2006-08-24 | Nestec S.A. | Oligosaccharide mixture |
EP1714660A1 (en) * | 2005-04-21 | 2006-10-25 | N.V. Nutricia | Uronic acid and probiotics |
WO2007010084A2 (en) | 2005-07-15 | 2007-01-25 | Johannes Savolainen | Immunostimulatory oligo- and polysaccharides and uses thereof |
EP1776877A1 (en) * | 2005-10-21 | 2007-04-25 | N.V. Nutricia | Method for stimulating the intestinal flora |
US20090156550A1 (en) | 2005-12-06 | 2009-06-18 | Potappel-Van T Land Belinda | Composition containing oligosaccharides for the treatment/prevention of infections |
EP1981526A4 (en) * | 2006-01-09 | 2011-03-02 | Childrens Hosp Medical Center | ADIPONECTIN FOR THE TREATMENT OF VARIOUS DISORDERS |
BRPI0708701A2 (pt) | 2006-03-10 | 2011-06-07 | Nutricia Nv | uso de um sacarìdeo não digerìvel solúvel em água |
WO2007114683A1 (en) | 2006-03-30 | 2007-10-11 | N.V. Nutricia | Milk oligosaccharides for stimulating the immune system |
US9239329B2 (en) | 2006-12-18 | 2016-01-19 | Japan Science And Technology Agency | Method of measuring interaction between biomaterial and sugar chain, method of evaluating biomaterial in sugar chain selectivity, method of screening biomaterial, method of patterning biomaterials, and kits for performing these methods |
WO2009067000A1 (en) | 2007-11-20 | 2009-05-28 | N.V. Nutricia | Composition with synbiotics |
EP2072052A1 (en) | 2007-12-17 | 2009-06-24 | Nestec S.A. | Prevention of opportunistic infections in immune-compromised subjects |
WO2010143940A1 (en) * | 2009-06-12 | 2010-12-16 | N.V. Nutricia | Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages |
CN106890329A (zh) | 2009-07-15 | 2017-06-27 | N·V·努特里奇亚 | 用于刺激免疫***的不可消化低聚糖的混合物 |
RU2530641C2 (ru) | 2009-07-15 | 2014-10-10 | Н.В. Нютрисиа | Фукозиллактоза в качестве неусвояемого олигосахарида, идентичного грудному молоку, с новой функциональной пользой |
US8802650B2 (en) | 2010-12-31 | 2014-08-12 | Abbott Laboratories | Methods of using human milk oligosaccharides for improving airway respiratory health |
US20160354395A1 (en) | 2013-11-15 | 2016-12-08 | Nestec S.A. | Infant formulas containing a 2-fucosylated oligosaccharide for treatment or prevention of influenza infection |
RU2694314C1 (ru) | 2013-12-12 | 2019-07-11 | Нестек С.А. | Искусственные питательные композиции, особенно адаптированные для младенцев и детей младшего возраста мужского и женского пола |
-
2010
- 2010-07-12 CN CN201611190648.5A patent/CN106890329A/zh active Pending
- 2010-07-12 EP EP10734842.7A patent/EP2453902B1/en not_active Revoked
- 2010-07-12 CN CN2010800409297A patent/CN102497868A/zh active Pending
- 2010-07-12 MY MYPI2016000875A patent/MY189329A/en unknown
- 2010-07-12 PL PL10734842T patent/PL2453902T3/pl unknown
- 2010-07-12 BR BR112012000760A patent/BR112012000760B8/pt active IP Right Grant
- 2010-07-12 US US13/383,823 patent/US20120178674A1/en not_active Abandoned
- 2010-07-12 WO PCT/NL2010/050446 patent/WO2011008086A1/en active Application Filing
- 2010-07-12 EP EP20130179261 patent/EP2662084A1/en not_active Withdrawn
- 2010-07-12 ES ES10734842T patent/ES2433429T3/es active Active
- 2010-07-12 CN CN201611190819.4A patent/CN107087793A/zh active Pending
- 2010-07-12 EP EP21178850.0A patent/EP3932410A1/en active Pending
-
2016
- 2016-11-23 US US15/360,524 patent/US10420784B2/en active Active
-
2019
- 2019-09-20 US US16/577,691 patent/US11090321B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20200222435A1 (en) | 2020-07-16 |
MY189329A (en) | 2022-02-04 |
BR112012000760B1 (pt) | 2021-04-27 |
RU2591831C2 (ru) | 2016-07-20 |
US10420784B2 (en) | 2019-09-24 |
EP2662084A1 (en) | 2013-11-13 |
EP2453902B1 (en) | 2013-08-07 |
CN102497868A (zh) | 2012-06-13 |
ES2433429T3 (es) | 2013-12-11 |
RU2012105313A (ru) | 2013-08-20 |
US11090321B2 (en) | 2021-08-17 |
CN106890329A (zh) | 2017-06-27 |
BR112012000760A2 (pt) | 2018-03-13 |
EP2453902A1 (en) | 2012-05-23 |
EP3932410A1 (en) | 2022-01-05 |
US20170232022A1 (en) | 2017-08-17 |
PL2453902T3 (pl) | 2014-01-31 |
CN107087793A (zh) | 2017-08-25 |
WO2011008086A1 (en) | 2011-01-20 |
US20120178674A1 (en) | 2012-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012000760B8 (pt) | composição nutricional | |
SV2015004969A (es) | Imidazo[1,2-a]piridincarboxamidas aminosustituidas y su uso | |
CO6390023A2 (es) | Anticuerpos anti-pd-l1 y su uso para mejorar la funcion de las celulas t | |
CL2012001050A1 (es) | Composicion nutricional parea lactantes y/o ninos que comprende lactoferrina y probioticos; metodo para preparar dicha composicion; kit. | |
CL2012001950A1 (es) | Uso de una cepa bacteriana probiotico en la fabricacion de un medicamento o composicion nutricional en humanos o animales para alterar los patrones del sueño | |
CL2011001320A1 (es) | Uso de composiciones que comprenden lactobacill rhamnosusus y bifidobacterium longum en la preparación de una formulación infantil para adelantar la alimentación entërica completa en niños prematuros con bajo peso al nacer | |
ZA201207377B (en) | Composition comprising probiotic bacteria for use in the treatment of immune disorders | |
BR112012030304A2 (pt) | método para aumentar a saúde de uma planta e uso de uma mistura | |
EP2797606A4 (en) | COMPOSITION AND USE OF A FORMULATION FOR INCREASING THE REPORT OF THE GASTROINTESTINAL MICROBIOTE OF THE PHYLUM OF BACTERIODITIES TO THE MICROBIOTE OF THE PHYLUM OF FIRMICUTES | |
CA2840307C (en) | Progenitor cells of mesodermal lineage | |
BR112015025709A2 (pt) | monoterapia com gla para uso em tratamento de câncer | |
IN2015DN03322A (pt) | ||
CL2011000146A1 (es) | Uso de bacterias probióticas para aumentar la secreción de inmunoglobulina a (iga) en un infante. | |
UY31942A (es) | Formulaciones de adyuvante comprendiendo combinaciones de triterpenoides, esteroles, inmunomoduladores, polímeros y estimuladores de th2, procedimientos de preparación, composiciones y aplicaciones. | |
UY35693A (es) | Pirazolo[1,5-a]piridin-3-carboxamidas sustituidas y su uso | |
CL2013001387A1 (es) | Arreglo de composiciones nutricionales complementarias para un lactante/niño pequeño; uso de dicho arreglo de composiciones para prevenir o tratar diarrea | |
IN2014CN02970A (pt) | ||
PL2707010T3 (pl) | Szczepy bakteryjne należące do rodzaju bifidobacterium do zastosowania w leczeniu hipercholesterolemii | |
UY34406A (es) | Compuestos y métodos para mejorar la respuesta inmune innata | |
CL2013001230A1 (es) | Composicion a base de cereales en polvo que comprenden microorganismos probioticos no replicantes; y su uso para prevenir o tratar desordenes inflamatorios o trastornos con una defensa inmune comprometida en lactantes o niños pequeños. | |
TWD173920S (zh) | 攪拌器的攪拌體 | |
CL2013000335A1 (es) | Forma altamente cristalina de valsartan; proceso para prepararla; composicion farmaceutica que la comprende y uso en el tratamiento de la hipertension. | |
BR112017010945A2 (pt) | uso de proteína vegetal hidrolisada enzimaticamente na preparação de bebidas fermentadas | |
AU340977S (en) | Carburetor float bowl | |
IN2014DN08407A (pt) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 6.21 NA RPI NO 2601 DE 10/11/2020 POR TER SIDO INDEVIDA. |
|
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 12/07/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME MEDIDA CAUTELAR DE 07/04/2021 - ADI 5.529/DF |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 12/07/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
B17A | Notification of administrative nullity (patentee has 60 days time to reply to this notification) |
Free format text: REQUERENTE DA NULIDADE: SOCIETE DES PRODUITS NESTLE S.A - 870210059086 - 30/06/2021 |
|
B16B | Notification of grant cancelled [chapter 16.2 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 16.3 NA RPI NO 2629 DE 25/05/2021 POR TER SIDO INDEVIDA. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: RETIFICACAO (REF. RPI 2625, DE 27/04/2021 - PRAZO DE VALIDADE: 10 (VINTE) ANOS CONTADOS A PARTIR DE 27/04/2021 OBSERVADAS AS CONDICOES LEGAIS. ) |